A randomized, single-dose, double-blind, active-controlled, 2-way crossover, study to assess the bioavailability of bisdemethoxycurcumin (BDMC) of a standardized turmeric extract (REVERC3) in healthy volunteers.

Vidya Herbs Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年5月30日

试验速览

暂无简介。

•1.Healthy volunteers who are not involved in any regular medication or supplementation.
•2.Subjects who are willing to give their written informed consent and comply with the protocol requirements.
•3.Females of childbearing age, agree to use approved birth control methods during the study, and have negative urine pregnancy test (UPT) at screening
•4.Subject understands the study procedures, is ready to comply and provide signed informed consent form (ICF) to participate in the study

•1.Subjects who have consumed curcumin (turmeric) containing food 2 days prior to screening
•2.Subjects having symptoms of viral infection, including COVID-19 infection
•3.Pregnant or lactating women.
•4.Subjects with known hypersensitivity to the investigational products.
•5.Subjects who have participated in any clinical trial in the past 1 month.
•6.Any subjects found to have entered into the study in violation of this protocol or if the subject is uncooperative during the study.
•7.Any other condition that in the opinion of the investigator that does not justify the subjectâ??s participation in the trial.

发起方